GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pharmigene Inc (ROCO:7595) » Definitions » Total Debt per Share

Pharmigene (ROCO:7595) Total Debt per Share : NT$12.22 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pharmigene Total Debt per Share?

NT$12.22 (As of Dec. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Pharmigene's Total Debt Per Share for the quarter that ended in Dec. 2024 was NT$12.22.

Pharmigene Total Debt per Share Historical Data

The historical data trend for Pharmigene's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmigene Total Debt per Share Chart

Pharmigene Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Debt per Share
Get a 7-Day Free Trial 0.50 0.34 0.22 11.32 12.22

Pharmigene Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 13.09 11.32 11.92 12.22

Pharmigene Total Debt per Share Calculation

Pharmigene's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(599.7+16.8)/50.5
=12.22

Pharmigene's Total Debt Per Share for the quarter that ended in Dec. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(599.7+16.8)/50.5
=12.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmigene Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Pharmigene's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmigene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pharmigene Inc (ROCO:7595) » Definitions » Total Debt per Share
Comparable Companies
ROCO:6615 ROCO:6661 ROCO:6939 ROCO:6847 TPE:6645 ROCO:4160 ROCO:4153 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH XPAR:BIM
Traded in Other Exchanges
N/A
Address
No. 17, Lane 171, Section 2, Jiuzong Road, 4th Floor, Neihu District, Taipei, TWN, 11494
Website
https://www.pharmigene.com
Pharmigene Inc is engaged in the development and sales of pharmaceutical genetic diagnostic products. Also, the company provides medical and drug testing services and equipment.

Pharmigene Headlines

No Headlines